CDC webinar for clinicians Thursday on synthetic cannabinoids
The Centers for Disease Control and Prevention will host a webinar Thursday for clinicians on synthetic cannabinoids, an emerging class of recreational drugs associated with a growing number of adverse events. The call will review the clinical effects of the drugs, which are smoked for their anticipated marijuana-like effects, and the role clinicians can play in the public health response. The 60-minute webinar begins at 1 p.m. ET.
Related News Articles
Headline
AHA and AMGA members may apply through Friday to participate in an intensive learning collaborative on managing population health and succeeding in the…
Headline
Boston Medical Center (BMC) has taken to heart Hippocrates 2,500-year-old dictum: “Let food be thy medicine and medicine be thy food.”BMC’s…
Headline
President Trump yesterday named Eric Hargan as Acting Secretary of Health and Human Services. Confirmed as HHS deputy secretary last week, Hargan previously…
Headline
The Centers for Medicare & Medicaid Services has approved a Section 1115 Medicaid demonstration waiver allowing West Virginia to expand its benefits…
Headline
More than 20 years ago, Cincinnati Children’s Hospital Medical Center nurse Erin Riehle came up with a novel idea for addressing her hospital’s…
Headline
More than 880,000 physicians were certified by the American Board of Medical Specialties in 2017, about 20,000 more than in 2016, according to the board’…